Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models
出版年份 2014 全文链接
标题
Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models
作者
关键词
-
出版物
HUMAN MOLECULAR GENETICS
Volume 23, Issue 23, Pages 6212-6222
出版商
Oxford University Press (OUP)
发表日期
2014-07-04
DOI
10.1093/hmg/ddu341
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain
- (2014) J. Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases
- (2013) W. J. Geldenhuys et al. CURRENT MEDICINAL CHEMISTRY
- Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011)
- (2012) Xianming Deng et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
- (2012) A. Biosa et al. HUMAN MOLECULAR GENETICS
- LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
- (2012) M. S. Moehle et al. JOURNAL OF NEUROSCIENCE
- LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: Suppression by curcumin
- (2012) Dejun Yang et al. NEUROBIOLOGY OF DISEASE
- The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
- (2012) Nicolas Dzamko et al. PLoS One
- Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
- (2012) Byoung Dae Lee et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome
- (2011) Cynthia Chester Cardoso et al. Future Microbiology
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
- (2011) Philip J. Webber et al. JOURNAL OF MOLECULAR BIOLOGY
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
- (2011) Mansoureh Hakimi et al. JOURNAL OF NEURAL TRANSMISSION
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
- (2011) Zhihua Liu et al. NATURE IMMUNOLOGY
- Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
- (2011) Xianting Li et al. PLoS One
- Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2—Discovery of LRRK2 inhibitors
- (2010) Min Liu et al. ANALYTICAL BIOCHEMISTRY
- Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities
- (2010) Min Liu et al. BIOCHEMISTRY
- Synphilin-1 attenuates neuronal degeneration in the A53T -synuclein transgenic mouse model
- (2010) W. W. Smith et al. HUMAN MOLECULAR GENETICS
- Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2
- (2010) Xiaojie Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LRRK2 Is Involved in the IFN- Response and Host Response to Pathogens
- (2010) A. Gardet et al. JOURNAL OF IMMUNOLOGY
- Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
- (2010) X. Li et al. JOURNAL OF NEUROSCIENCE
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
- (2010) Taye H Hamza et al. NATURE GENETICS
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- (2010) Byoung Dae Lee et al. NATURE MEDICINE
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
- (2010) Yulan Xiong et al. PLoS Genetics
- Development of Extracellular Signal-Regulated Kinase Inhibitors
- (2009) Kimberly Burkhard et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- LRRK2 in Parkinson’s disease: genetic and clinical studies from patients
- (2009) Udhaya Kumari et al. FEBS Journal
- CHARMM: The biomolecular simulation program
- (2009) B. R. Brooks et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
- (2008) Saskia Biskup et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Identification and Validation of Human DNA Ligase Inhibitors Using Computer-Aided Drug Design
- (2008) Shijun Zhong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
- (2008) Payal N. Gandhi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The biology and pathobiology of LRRK2: Implications for Parkinson's disease
- (2008) Darren J. Moore PARKINSONISM & RELATED DISORDERS
- Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
- (2008) J. Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started